Log In Sign Up

Trading

Trading

Browse Companies

Data

Data

IPO Stock Tracker

Solutions

Solutions

For Institutions

For Shareholders

Insights

Insights

Popular Topics

Buying Pre-IPO Shares

Selling Pre-IPO Shares

Private Market Reports

Private Market Data & Analytics

About

About

Investor Relations

People & Culture

VisionGate Stock

visiongate3d.comHealthcareFounded: 1900Funding to Date: $49.27MM

VisionGate is a clinical stage oncology pharmaceutical and diagnostics company with a focus on the early detection and treatment of lung cancer and bronchial dysplasia.

Buy or sell VisionGate stock Learn more about VisionGate IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for VisionGate.

Register Today

Team

Management Team

Michael Meyer

Chief Technology Officer

Randall Mastrangelo

Vice President, Global Commercial Strategy, Marketing and Sales

Vishu Jhaveri MD

Strategic Advisor

Randal Buness

Chief Financial Officer

Jon Hayenga

Vice President, Advanced Product Development

Javier Zulueta MD

Chief Medical Officer & Advisor, Medical

Alan Nelson Ph.D

Chief Executive Officer, Chairman & Founder

Scarlett Spring

President & Chief Commercial Officer

Chris Presley

Director of Clinical Research

Stephen Phillips

Vice President, Quality Systems

Board Members

James Burns

Reginald Ballantyne III

Thomas Miller

GreyBird Ventures

Alan Nelson Ph.D

Robert Heft Ph.D

Walter Robb

Maria Forero

Paul Kelly

Sharon Everson

Other companies like VisionGate in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Colossal Biosciences

Sector

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$400.53MM

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Precision Neuroscience

Sector

Frequently Asked Questions